For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Medical Cannabis, A brief guide for New Zealanders
+News
In print
Summer Hiatus
Medical Cannabis, A brief guide for New Zealanders
Tuesday 7 January 2020, 09:00 AM

We are on our summer break and the editorial office is closed until 13 January. We hope you enjoy this article which is part of Summer Hiatus, an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading
Shaun Holt and Emma Dalton
Published by Potton & Burton
Softcover, 353pp, $29.99
Millions of people are using cannabis for medical reasons, wheth
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.